A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One looming question: Will it be affordable for lower resource countries?
The testing of lenacapavir was halted because results were so impressive — 100% effectiveness. The decision was made to give all participants the injection rather than the alternative daily pill.
Broadbent, diagnosed at age 3, was one of the first generation of children born HIV positive, and known for raising awareness to lessen the stigma of the disease from a young age. She died Tuesday.
A significant number of new HIV infections happen among Black women, and a health education effort in Atlanta wants to make sure Black women can access the HIV-prevention medicines known as PrEP.
Emory’s Hope Clinic and Vaccine Center is one of four sites in the country participating in the study. The ultimate goal is to vaccinate people against HIV, the virus that causes AIDS.
As the first Black transgender woman to serve in this capacity, Tori Cooper says she is eager to advocate on behalf of all transgender and non-binary people living with HIV.
The target numbers, focusing on kids, teens and young women, were part of the 5-year "Start Free, Stay Free, AIDS Free" program. What went wrong? Is there hope for improvement in the future?
Experts fear steep declines in testing and diagnoses mean more people will contract HIV and die of AIDS. The problem is particularly acute in the South, the epicenter of the nation's HIV crisis.
At the international AIDS conference last week — held virtually — concerns were shared about the impact of the novel coronavirus on efforts to fight AIDS.
Last year, U.S. retail sales of essential oils topped $133 million. That number doesn’t include sales from multi-level marketers, who sell directly to...
